Soleno Therapeutics

SLNO · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: -$1.27

-164.6%

Weighted-Avg Shares (Basic)

53.18M

Q4 Patient Start Forms

207

New Unique Prescribers

136

Gross Profit

$90.9M

Previous year: -$503K

-18165.0%

Cash and Equivalents

$70.1M

Previous year: $87.9M

Loading...

Soleno Therapeutics

Unlock previous datapoints

Upgrade

Soleno Therapeutics

Unlock previous datapoints

Upgrade

Soleno Therapeutics Revenue by Segment

Soleno Therapeutics Revenue by Geographic Location

Revenue by Segment

VYKAT XR Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.57B

P/E Ratio

-35.77

Sector

N/A

Industry

N/A

52-Week High

$88.3

52-Week Low

$30.1

Weighted-Avg Shares (Basic)

53.18M

Q4 Patient Start Forms

207

New Unique Prescribers

136

R&D Expense

$9.56M

SG&A Expense

$40.9M

Products

Get in Touch

Resources

Soleno Therapeutics

Soleno Therapeutics

Soleno Therapeutics

Soleno Therapeutics Revenue by Segment

Soleno Therapeutics Revenue by Geographic Location

Revenue by Segment

VYKAT XR Revenue

Revenue by Geographic Location

United States Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics